A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities

Name: A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
Published: 2023
License: Public Domain

Zydus Lifesciences Limited · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

metabolic-syndrome obesity type-2-diabetes

nafld, obesity, type 2 diabetes, dyslipidemias, metabolic syndrome, real world evidence study, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities

Related documents